Richard Kemp
- Molecular Biology top 5%
- Oncology top 2%
- Cancer Research top 5%
- Genetics top 5%
- Cell Biology top 5%
- Co-authors
- Douglas J. WintonAnna M. NicholsonLouis VermeulenSimon J. A. BuczackiHeather ZecchiniLawrence G. FoeRoslin RussellWilliam D. Riley
- Topics
- Cancer, Hypoxia, and Metabolism (14 papers)Metabolism, Diabetes, and Cancer (13 papers)Cancer Cells and Metastasis (9 papers)
- Partner nations
- United StatesUnited KingdomNetherlands
In The Last Decade
Richard Kemp
48 papers receiving 2.8k citations
Hit Papers
Peers
Comparison fields: 5 of 111
- Molecular Biology 1.9k
- Oncology 1.0k
- Cancer Research 591
- Genetics 554
- Cell Biology 396
Countries citing papers authored by Richard Kemp
This map shows the geographic impact of Richard Kemp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard Kemp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard Kemp more than expected).
Fields of papers citing papers by Richard Kemp
This network shows the impact of papers produced by Richard Kemp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard Kemp. The network helps show where Richard Kemp may publish in the future.
Co-authorship network of co-authors of Richard Kemp
This figure shows the co-authorship network connecting the top 25 collaborators of Richard Kemp. A scholar is included among the top collaborators of Richard Kemp based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard Kemp. Richard Kemp is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 0 | |
| 3 | 10 | |
| 4 | 2 | |
| 5 | 7 | |
| 6 | 72 | |
| 7 | 60 | |
| 8 | 53 | |
| 9 | 295 | |
| 10 | Intestinal label-retaining cells are secretory precursors expressing Lgr5breakdown → | 568 |
| 11 | 159 | |
| 12 | 152 | |
| 13 | 153 | |
| 14 | 12 | |
| 15 | 285 | |
| 16 | 68 | |
| 17 | 10 | |
| 18 | 2 | |
| 19 | 28 | |
| 20 | 27 |
About Richard Kemp
Richard Kemp is a scholar working on Cancer Research, Endocrinology, Diabetes and Metabolism and Molecular Biology, having authored 49 papers that have together received 3.0k indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (14 papers), Metabolism, Diabetes, and Cancer (13 papers) and Cancer Cells and Metastasis (9 papers). The work is most often cited by research in Cancer Research (591 citations), Oncology (1.0k citations) and Molecular Biology (1.9k citations). Richard Kemp has collaborated with scholars based in United States, United Kingdom and Netherlands. Frequent co-authors include Douglas J. Winton, Anna M. Nicholson, Louis Vermeulen, Simon J. A. Buczacki, Heather Zecchini, Lawrence G. Foe, Roslin Russell, William D. Riley, E G Krebs and R J DeLange. Their work appears in journals such as Nature, Science and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.